
Price
$0.00
无数据
无数据
无数据
| CAS Number | 2022-85-7 |
| Catalog Number | AG002851(AGN-PC-0O76SU) |
| Chemical Name | 2(1H)-Pyrimidinone, 6-amino-5-fluoro- |
| EC Number | 217-968-7 |
| IUPAC Name | 6-amino-5-fluoro-1H-pyrimidin-2-one |
| InChI | InChI=1S/C4H4FN3O/c5-2-1-7-4(9)8-3(2)6/h1H,(H3,6,7,8,9) |
| InChI Key | XRECTZIEBJDKEO-UHFFFAOYSA-N |
| MDL Number | MFCD00006035 |
| Molecular Formula | C4H4FN3O |
| Molecular Weight | 129.0925 |
| SMILES | O=C1NC(=C(F)C=N1)N |
| UNII | D83282DT06 |
| Synonyms | 5-Fluorocytosine,
Alcobon,
Ancobon,
Ancotil,
Flucytosine,
5-Fluorocytosine,
flucytosine,
2022-85-7,
Ancotil,
Ancobon,
5-Fluorocystosine,
Flucytosin,
Fluocytosine,
5-FC,
5-Fluorocytosin,
Fluorcytosine,
Alcobon,
4-Amino-5-fluoropyrimidin-2(1H)-one,
Flucytosinum,
4-Amino-5-fluoro-2(1H)-pyrimidinone,
Ro 2-9915,
Cytosine, 5-fluoro-,
Flucitosina,
5-Flurocytosine,
5-Flucytosine,
2(1H)-Pyrimidinone, 4-amino-5-fluoro-,
2-Hydroxy-4-amino-5-fluoropyrimidine,
5-fluoro cytosine,
Flucitosina [DCIT],
Flucystine,
Ro 29915 E/265601,
NSC 103805,
Flucytosinum [INN-Latin],
Ancobon (TN),
Flucytosine (Ancobon),
4-Amino-5-fluoro-2-hydroxypyrimidine,
117969-88-7,
4-amino-5-fluoropyrimidin-2-ol,
Flucytosine(Ancobon),
UNII-D83282DT06,
HSDB 3082,
2-Pyrimidinol, 4-amino-5-fluoro- (9CI),
6-Amino-2-oxo-5-fluoropyrimidine,
EINECS 217-968-7,
MFCD00006035,
6-amino-5-fluoro-1H-pyrimidin-2-one,
2(1H)-Pyrimidinone, 4-amino-5-fluoro-),
MLS000069463,
CHEBI:5100,
4-AMINO-2-HYDROXY-5-FLUOROPYRIMIDINE,
XRECTZIEBJDKEO-UHFFFAOYSA-N,
NSC103805,
D83282DT06,
4-Amino-5-fluoro-1H-pyrimidin-2-one,
NCGC00016599-01,
CPD000059047,
SMR000059047,
ST028644,
2(1H)-Pyrimidinone, 6-amino-5-fluoro-,
6-amino-5-fluoro-3-hydropyrimidin-2-one,
CAS-2022-85-7,
DSSTox_CID_3059,
6-amino-5-fluoro-1,2-dihydropyrimidin-2-one,
5-Fluorocytosine, 99+%,
C4H4FN3O,
DSSTox_RID_76856,
DSSTox_GSID_23059,
Flucytosone,
5-FLUORO-4-IMINO-1,2,3,4-TETRAHYDROPYRIMIDIN-2-ONE,
Ancotyl,
Flucytosine [USAN:INN:BAN:JAN],
flucytosina,
5-fluorocytocine,
Flucytosine,(S),
5 Fluoro Cytosine,
4-Amino-5-fluoro-2-hyroxypyrimidine,
zlchem 343,
Flucytosine [USAN),
Flucytosine (5-FC),
Flucytosine [USAN:USP:INN:BAN:JAN],
ACMC-209zxs,
Opera_ID_178,
AC1L1FRT,
Prestwick0_000934,
Prestwick1_000934,
Prestwick2_000934,
Prestwick3_000934,
F0321,
EC 217-968-7,
AC1Q52OQ,
WLN: T6MVNJ DZ EF,
CHEMBL1463,
SCHEMBL24063,
BSPBio_000868,
130256-61-0,
MLS000759519,
MLS001076503,
MLS001424013,
Flucytosine, 5-Fluorocytosine,
SPBio_003037,
BPBio1_000956,
Flucytosine (JP17/USP/INN),
DTXSID3023059,
SCHEMBL14696800,
4-Amino-5-fluoro-2-pyrimidinol,
CTK7B7906,
CTK7E0508,
CTK8A0854,
QCR-271,
ZLC0185,
4-amino-5-fluoro-pyrimidin-2-ol,
HMS1570L10,
HMS2051M04,
HMS2093J05,
HMS2097L10,
HMS2233I14,
HMS3373L05,
HMS3393M04,
HMS3655G17,
HMS3714L10,
Pharmakon1600-01505429,
ZINC896546,
5-Fluorocytosine, nucleoside analog,
AMX10130,
BCP02877,
Flucytosine 2.0 mg/ml in Methanol,
HY-B0139,
Tox21_110515,
ANW-50846,
CF-075,
MFCD00179326,
MFCD03547958,
NSC759130,
Ro-29915,
s1666,
SBB000061,
STK292386,
AKOS004912683,
AKOS005063821,
AKOS015896898,
AKOS030241326,
Tox21_110515_1,
2-Hydroxy-4-amino-5-fluoro-pyrimidine,
6-amino-5-fluoropyrimidin-2(1H)-one,
AN-9456,
BCP9000692,
CCG-100837,
CCG-213434,
CS-1935,
DB01099,
GS-5578,
KS-1060,
LS40595,
MCULE-7094058995,
NC00087,
NSC-103805,
NSC-759130,
KS-00000A18,
Cytosine, 5-fluoro- (6CI,7CI,8CI),
NCGC00016599-02,
NCGC00016599-04,
NCGC00016599-05,
AC-11748,
AJ-24237,
AK-33991,
BC203393,
BP-30254,
BR-33991,
LS-59140,
NCI60_000093,
SAM001246753,
SC-09037,
SY004438,
ZB015095,
BCP0726000281,
AB0005647,
AB0071040,
AB1000113,
DB-005380,
TL8001667,
4-AMINO-5-FLUORO-2(1H)-PYRIMIDINE,
AB00513969,
AM20090149,
FT-0601273,
SW197278-3,
5-fluoro-4-imino-1,3-dihydropyrimidin-2-one,
22P857,
4-Amino-1,2-dihydro-5-fluoro-2-oxopyrimidine,
B-7734,
D00323,
F-3010,
16469-EP2281563A1,
16469-EP2316459A1,
AB00444223-16,
AB00513969-02,
AB00513969_03,
AB00513969_04,
MFCD00006035 (97+%),
4-amino-5-fluoro-2(1H)-pyrimidinone; Flucytosine,
5-Fluorocytosine, Vetec(TM) reagent grade, 99%,
SR-01000721885,
Flucytosine|||6-Amino-5-fluoropyrimidin-2(1H)-one,
I07-0006,
SR-01000721885-5,
BRD-K82143716-001-15-7,
5-Fluorocytosine, Antibiotic for Culture Media Use Only,
Flucytosine, European Pharmacopoeia (EP) Reference Standard,
Flucytosine, United States Pharmacopeia (USP) Reference Standard,
Flucytosine, Pharmaceutical Secondary Standard; Certified Reference Material,
Flucytosine for system suitability, European Pharmacopoeia (EP) Reference Standard,
1LD,
Fluorocytosine,
Necrostatin-1,
5-fluoro-cytosine,
5-Fluorocytosine-6-3H,
D0S5WG,
Flucytosine (JP15/USP/INN),
5-Fluorocytosine, 98% 250mg,
CID3366,
C4-H4-F-N3-O,
DRG-0049,
Flucytosine [USAN:BAN:INN:JAN],
Ro-2-9915,
5-Fluorocytosine, 98% - 1G 1g,
6-Amino-5-fluoro-2(1H)-pyrimidinone,
ACN-036605,
Cytosine, 5-fluoro-(6CI,7CI,8CI),
GL663142 & 5FC,
5987P,
9074P,
A8433,
LT00771985,
4-amino-5-fluoro-1,2-dihydropyrimidin-2-one,
A10394,
D005437,
GL663142 & 4-Amino-5-fluoropyrimidin-2(1H)-one,
2(1H)-Pyrimidinone, 5-fluoro-3,4-dihydro-4-imino- (9CI),
4-imidazolidinone, 5-(1H-indol-3-ylmethyl)-3-methyl-2-thioxo-,
4311-88-0,
|
| Complexity | 208 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 129.034g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 9 |
| Hydrogen Bond Acceptor Count | 3 |
| Hydrogen Bond Donor Count | 2 |
| Isotope Atom Count | 0 |
| Molecular Weight | 129.094g/mol |
| Monoisotopic Mass | 129.034g/mol |
| Rotatable Bond Count | 0 |
| Topological Polar Surface Area | 67.5A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | -0.9 |
| Symbol: | |
| Hazard Class | |
| Hazard statements | H302 |
| Packing Group | |
| Precautionary statements | P280-P305+P351+P338 |
| UN Code |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

